Skip to Content
 

News: Patient Care

Journey Home Project supports first CAR-T infusion at VA hospital

Thursday, January 16th, 2020

The Tennessee Valley Healthcare System performed its first CAR-T infusion recently at the Veterans Administration hospital in Nashville.

ACMG advises evaluating all breast cancer patients to determine the need for genetic testing

Friday, December 13th, 2019

According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.

New telehealth initiative aims to enhance cancer care in rural areas

Thursday, September 19th, 2019

VUMC is leading an effort to improve cancer care in rural areas with a telehealth initiative supported with a $3.3 million grant from the National Cancer Institute.

Jackson named to new VICC advanced practice role

Wednesday, September 18th, 2019

Heather Jackson, MSN, RN, APRN, has been promoted to administrative director of Advanced Practice for Vanderbilt-Ingram Cancer Center.

Colorectal cancer patients warn against dismissing early symptoms

Friday, August 9th, 2019

Younger patients say colorectal cancer is a disease that doesn’t follow age guidelines, so pay attention to early symptoms.

Hand-held robot points to less invasive prostate surgery

Friday, July 19th, 2019

Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options.

Clinical study tests drug that may prevent cancer metastasis

Thursday, July 11th, 2019

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

Expert Q&A: Understanding a new approach to cancer treatment

Saturday, June 29th, 2019

Precision oncology expert Dr. Ben Ho Park sheds light on cancer treatment innovations.

Childhood cancer: how it’s different than for adults

Saturday, June 29th, 2019

The nature of childhood cancer is different than adult cancer, and so is the approach to treatment.

Treatment approved for patients with acute graft-versus-host disease

Saturday, June 29th, 2019

The U.S. Food and Drug Administration (FDA) recently approved ruxolitinib, the first drug for patients with acute graft-versus-host disease (GVHD) who have an inadequate response to steroid treatment.

Next Page »